These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Characterization of iron metabolism and erythropoiesis in erythrocyte membrane defects and thalassemia traits. Sulovska L, Holub D, Zidova Z, Divoka M, Hajduch M, Mihal V, Vrbkova J, Horvathova M, Pospisilova D. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Jun; 160(2):231-7. PubMed ID: 26592557 [Abstract] [Full Text] [Related]
31. Hepcidin is suppressed by erythropoiesis in hemoglobin E β-thalassemia and β-thalassemia trait. Jones E, Pasricha SR, Allen A, Evans P, Fisher CA, Wray K, Premawardhena A, Bandara D, Perera A, Webster C, Sturges P, Olivieri NF, St Pierre T, Armitage AE, Porter JB, Weatherall DJ, Drakesmith H. Blood; 2015 Jan 29; 125(5):873-80. PubMed ID: 25519750 [Abstract] [Full Text] [Related]
32. Erythroferrone, the new iron regulator: evaluation of its levels in Egyptian patients with beta thalassemia. El-Gamal RAE, Abdel-Messih IY, Habashy DM, Zaiema SEG, Pessar SA. Ann Hematol; 2020 Jan 29; 99(1):31-39. PubMed ID: 31834456 [Abstract] [Full Text] [Related]
35. Hepcidin-to-Ferritin Ratio as an Early Diagnostic Index of Iron Overload in β-Thalassemia Major Patients. Zaman BA, Ibrahim SA. Hemoglobin; 2022 Mar 29; 46(2):106-113. PubMed ID: 35930276 [Abstract] [Full Text] [Related]
40. Soluble transferrin receptor levels and soluble transferrin receptor/log ferritin index in the evaluation of erythropoietic status in childhood infections and malignancy. Dimitriou H, Stiakaki E, Markaki EA, Bolonaki I, Giannakopoulou C, Kalmanti M. Acta Paediatr; 2000 Oct 29; 89(10):1169-73. PubMed ID: 11083370 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]